HuMog Side Effects

In the female, a local reaction at the injection site, fever and arthralgia have been observed in rare cases. In the male, a combined treatment with HuMoG and HuCoG may cause gynecomastia.
Occasionally, nausea and vomiting can occur.
In single cases, hypersensitivity reactions and fever can occur during treatment with HuMoG. The administration of HuMoG may lead to reactions at the injection site: reddening, pain, swelling and itching. In very rare cases, long-term usage can lead to the formation of anti-bodies, making the therapy ineffective.
Treatment with HuMoG can often lead to ovarian hyperstimulation that first becomes clinically relevant after the administration of HuCoG (pregnancy hormone) to induce ovulation. This can lead to the formation of large ovarian cysts that tend to rupture, and to intraabdominal bleeding. In addition, the accumulation of fluids in the abdominal cavity (ascites), the accumulation of fluids in the chest cavity (hydrothorax), a decrease in the excretion of urine (oliguria), lowering of the blood pressure (hypotension), and occlusion of blood vessels by blood clots (thromboembolic phenomena) can occur.
Treatment should be immediately discontinued when the first signs of hyperstimulation appear: abdominal pain and a palpable (by the physician) enlargement in the lower abdomen, which can be detected sonographically.
If abdominal pain occurs, see a physician.
If pregnancy occurs, these side effects can intensify, continues over a long period of time, and be life-threatening.
Unintentional multiple pregnancies occur more often during treatment with HuMoG.